| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 6.84 mm | 6.84 mm | 6.84 mm | 6.84 mm | 6.84 mm | 6.84 mm |
| Cash burn (monthly) | 153.01 k | 244.71 k | 166.49 k | 363.41 k | 153.01 k | 244.71 k |
| Cash used (since last report) | 784.24 k | 1.25 mm | 853.32 k | 1.86 mm | 784.24 k | 1.25 mm |
| Cash remaining | 6.06 mm | 5.59 mm | 5.99 mm | 4.98 mm | 6.06 mm | 5.59 mm |
| Runway (months of cash) | 39.6 | 22.8 | 36.0 | 13.7 | 39.6 | 22.8 |
| 13F holders | Current |
|---|---|
| Total holders | 10 |
| Opened positions | 6 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 200.68 mm |
| Total shares | 463.37 k |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| OPK OPKO Health | 267.14 k | $429.00 k |
| CLS Therapeutics | 147.50 k | $626.00 k |
| Sachetta | 17.37 k | $75.04 mm |
| Renaissance Technologies | 15.85 k | $68.47 mm |
| Geode Capital Management | 11.89 k | $52.10 mm |
| JTC Employer Solutions Trusteee | 2.70 k | $12.00 k |
| Tower Research Capital | 692.00 | $2.99 mm |
| JPM JPMorgan Chase & Co. | 200.00 | $876.00 k |
| BAC Bank of America | 29.00 | $126.00 k |
| Harwood Advisory | 2.00 | $9.00 k |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Dec 24 | Firdaus J. Dastoor | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 11 Dec 24 | Kornberg Roger D. | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 11 Dec 24 | Borisenko Grigory G. | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 11 Dec 24 | Alexey Andreevich Vinogradov | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 18 Jun 24 | James F Parslow | Stock Options Common Stock | Grant | Acquire A | No | No | 3.99 | 20,000 | 79.80 k | 20,000 |
